Potential and current use of N-methyl-D-aspartate (NMDA) receptor antagonists in diseases of aging (Q34458418)

2 August 2017

1 reference

title

Potential and current use of N-methyl-D-aspartate (NMDA) receptor antagonists in diseases of aging (English)

1 reference

2 August 2017

Le DA

1

1 reference

PubMed ID

11735619

2 August 2017

Lipton SA

series ordinal

2

1 reference

2 August 2017

1 January 2001

1 reference

2 August 2017

1 reference

2 August 2017

18

1 reference

2 August 2017

10

1 reference

2 August 2017

717-724

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200118100-00001

2 August 2017

0 references

cites work

Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats

1 reference

12 December 2020

Memantine stimulates inositol phosphates production in neurones and nullifies N-methyl-D-aspartate-induced destruction of retinal neurones

1 reference

12 December 2020

Cerestat and other NMDA antagonists in ischemic stroke

1 reference

12 December 2020

Clinical experience with excitatory amino acid antagonist drugs

1 reference

12 December 2020

The problem of assessing effective neuroprotection in experimental cerebral ischemia

1 reference

12 December 2020

Dopamine/glutamate interactions in Parkinson's disease

1 reference

12 December 2020

Neuronal plasticity: increasing the gain in pain

1 reference

12 December 2020

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

1 reference

12 December 2020

To what extent have functional studies of ischaemia in animals been useful in the assessment of potential neuroprotective agents?

1 reference

12 December 2020

Actions of redox-related congeners of nitric oxide at the NMDA receptor

1 reference

12 December 2020

Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures.

1 reference

12 December 2020

Lines of therapeutics research in Alzheimer's disease

1 reference

12 December 2020

Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate

1 reference

12 December 2020

Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide

1 reference

12 December 2020

Memantine prevents quinolinic acid-induced hippocampal damage

1 reference

12 December 2020

Parkinson's disease in epidemiologic perspective

1 reference

12 December 2020

Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus.

1 reference

12 December 2020

NMDA receptor channels: subunit-specific potentiation by reducing agents

1 reference

12 December 2020

Neuroprotective effect of memantine demonstrated in vivo and in vitro.

1 reference

12 December 2020

Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging

1 reference

12 December 2020

The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review

1 reference

12 December 2020

d-Cycloserine enhances implicit memory in Alzheimer patients.

1 reference

12 December 2020

Experimental neuronal protection in cerebral ischaemia part I: experimental models and pathophysiological responses

1 reference

12 December 2020

Characterization of nociceptin/orphanin FQ-induced pain responses in conscious mice: neonatal capsaicin treatment and N-methyl-D-aspartate receptor GluRepsilon subunit knockout mice

1 reference

12 December 2020

Antidepressants for the new millennium

1 reference

12 December 2020

Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon

1 reference

12 December 2020

Memantine prevents HIV coat protein-induced neuronal injury in vitro

1 reference

12 December 2020

Delayed administration of memantine prevents N-methyl-D-aspartate receptor-mediated neurotoxicity

1 reference

12 December 2020

'Vascular depression' hypothesis

1 reference

12 December 2020

A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds.

1 reference

12 December 2020

Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies

1 reference

12 December 2020

Diagnosis and management of Alzheimer disease.

1 reference

12 December 2020

Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A

1 reference

12 December 2020

Antidepressant effects of ketamine in depressed patients

1 reference

12 December 2020

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity

1 reference

12 December 2020

Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation

1 reference

12 December 2020

The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders

1 reference

12 December 2020

Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism

1 reference

12 December 2020

Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures

1 reference

12 December 2020

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

1 reference

12 December 2020

Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO-.

1 reference

12 December 2020

Excitatory amino acids as a final common pathway for neurologic disorders.

1 reference

12 December 2020

Glutamate neurotoxicity and diseases of the nervous system

1 reference

12 December 2020

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

1 reference

12 December 2020

Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation

1 reference

12 December 2020

Glumate receptor dysfunction and Alzheimer's disease.

1 reference

12 December 2020

The role of excitotoxicity in neurodegenerative disease: implications for therapy

1 reference

12 December 2020

Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat.

1 reference

12 December 2020

Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist

1 reference

12 December 2020

Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine

1 reference

12 December 2020

Excitotoxins in neuronal apoptosis and necrosis

1 reference

12 December 2020

GlycineB antagonists and partial agonists in rodent models of Parkinson's disease--comparison with uncompetitive N-methyl-D-aspartate receptor antagonist

1 reference

12 December 2020

Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes?

1 reference

12 December 2020

1 reference

12 December 2020

Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases

1 reference

12 December 2020

The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes.

1 reference

12 December 2020

gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine

1 reference

12 December 2020

Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex

1 reference

12 December 2020

Treatment of acute ischemic stroke

1 reference

12 December 2020

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

12 December 2020

Three pairs of cysteine residues mediate both redox and zn2+ modulation of the nmda receptor.

1 reference

12 December 2020

The antiparkinsonian agent budipine is an N-methyl-D-aspartate antagonist.

1 reference

12 December 2020

NMDA-receptor regulation of substance P release from primary afferent nociceptors

1 reference

12 December 2020

Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators

1 reference

12 December 2020

Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor

1 reference

12 December 2020

New approaches to pain control in patients with cancer

1 reference

12 December 2020

10.2165/00002512-200118100-00001

Identifiers

DOI

1 reference

PubMed ID

11735619

Dimensions Publication ID

2 August 2017

0 references

1 reference

PubMed ID

11735619